miércoles, 25 de julio de 2018

Cancer Information Highlights, July 25, 2018

Cancer Information Highlights, July 25, 2018

National Cancer Institute



Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Cancer Prevention Message is Key When Discussing the HPV Vaccine with Parents
infographic of doctor and possible ways of introducing the HPV vaccine In a new study, researchers asked parents to select the best and worst reasons a doctor might give to support HPV vaccination for their kids. Find out how researchers are using information from this study to improve the way parents and doctors talk about HPV vaccines.
Video—GIST Clinic Facebook Live Event

If you missed the live broadcast, you can now watch the recording of our Facebook Live event. Listen as experts discuss the NIH Pediatric and Wildtype GIST Clinic and its contributions to advancing research on gastrointestinal stromal tumors (GIST).
Drug Prevents Chemo-Related Hearing Loss in Some Children
An inner ear  Cisplatin treatment can cause hearing loss in children with cancer. Learn how hearing loss can be prevented in some of these children.
The Opioid Epidemic and Cancer Pain Management
woman holding pill and glass of water
 
 Opioids are an important part of managing some types of cancer pain. Learn how the opioid epidemic is affecting cancer patients and their providers in this conversation with Judith Paice, Ph.D., R.N.
Drug Information Updates
Atezolizumab for Urothelial Cancer

We’ve updated our summary on atezolizumab (Tecentriq). The Food and Drug Administration (FDA) recently limited the drug’s approval in urothelial cancer to patients whose cancers test positive for the PD-L1 protein and cannot be treated with cisplatin or whose cancers have gotten worse during or after treatment with platinum chemotherapy.
New Approvals for Melanoma

We’ve added new drug information summaries for binimetinib (Mektovi) and encorafenib (Braftovi), which were recently approved by FDA to be used together to treat melanoma that has a certain mutation in the BRAF gene.
Fostamatinib Disodium for Thrombocytopenia

We’ve added a new drug information summary for fostamatinib disodium (Tavalisse). It was recently approved by FDA to treat thrombocytopenia (low platelet levels) in patients with chronic immune thrombocytopenia that did not get better with other treatment.
 
Also of Interest
Managing Costs and Medical Information

People with cancer and their families may face major financial challenges, even when they have insurance. Learn tips for managing costs and keeping track of paperwork and bills.
Pain in People with Cancer

Pain is a common symptom of cancer and side effect of its treatment. Learn why it’s important to have a pain control plan, how to track your levels of pain, and ways to treat pain.
Gastrointestinal Stromal Tumors (GIST) Treatment

GIST are usually found in the stomach or small intestine, but they can occur in any part of the GI tract. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for GIST.

No hay comentarios:

Publicar un comentario